TNF-α as a therapeutic target in acute pancreatitis - Lessons from experimental models

TheScientificWorldJournal

Volumn 7, Issue , 2007, Pages 431-448

  Malleo, Giuseppe ^a   Mazzon, Emanuela ^a,b   Siriwardena, Ajith K ^c   Cuzzocrea, Salvatore ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Anti TNF therapy; Clinical trial; Cytokines; Experimental pancreatitis

Indexed keywords

5 (2,2 DICYANOVINYL) 2 NITROPHENOL; 6 (4 FLUOROPHENYL) 2,3 DIHYDRO 5 (4 PYRIDYL)IMIDAZO[2,1 B]THIAZOLE; ADENOSINE; BATIMASTAT; ETANERCEPT; ILOPROST; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 13; MONOCLONAL ANTIBODY; N (4 BUTYLPHENYL) ALPHA CYANOCAFFEIC ACID AMIDE; PENTOXIFYLLINE; POLYCLONAL ANTIBODY; REACTIVE OXYGEN METABOLITE; RECOMBINANT TUMOR NECROSIS FACTOR; ROLIPRAM; SEMAPIMOD; THALIDOMIDE; THALIDOMIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR; TYRPHOSTIN; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

ACINAR CELL; ACUTE LUNG INJURY; ACUTE PANCREATITIS; APOPTOSIS; BLOOD VESSEL INJURY; DIET; DISEASE COURSE; DRUG MECHANISM; GENE EXPRESSION; INFLAMMATION; LIVER FAILURE; MACROPHAGE; MONOCYTE; NECROSIS; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; SHOCK; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; EVIDENCE-BASED MEDICINE; HUMANS; PANCREATITIS, ACUTE NECROTIZING; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 34047226686     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2007.98     Document Type: Review

References (98)

1. Working Party of the British Society of Gastroenterology: Association of Surgeons of Great Britain and Ireland: Pancreatic Society of Great Britain and Ireland: Association of Upper GI Surgeons of Great Britain and Ireland (2005) UK guidelines for the management of acute pancreatitis. Gut 54, 1-9.
2. Granger, J. and Remick, D. (2005) Acute pancreatitis: models, markers, and mediators. Shock 24, 45-51.
3. Mayer, J., Rau, B., Gansauge, F., and Beger, H.G. (2000) Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 47, 546-552.
4. Hehlgans, T. and Pfeffer, K. (2005) The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 115, 1-20.
5. Volman, T.J., Hendriks, T., Verhofstadt, A.A., Kullberg, B.J., and Goris, R.J. (2002) Improved survival of TNF-deficient mice during the zymosan-induced multiple organ dysfunction syndrome. Shock 17, 468-472.
6. Norman, J. (1998) The role of cytokines in the pathogenesis of acute pancreatitis. Am. J. Surg. 175, 76-83.
7. Bhatia, M., Wong, F.L., Cao, Y., Lau, H.Y., Huang, J., Puneet, P., and Chevali, L. (2005) Pathophysiology of acute pancreatitis. Pancreatology 5, 132-144.
8. Schafer, C., Tietz, A.B., and Goke, B. (2005) Pathophysiology of acute experimental pancreatitis: lessons from genetically engineered animal models and new molecular approaches. Digestion 71, 162-172.
9. Genovese, T., Mazzon, E., Di Paola, R., Muià, C., Crisafulli, C., Malleo, G., Esposito, E., and Cuzzocrea, S. (2006) Role of peroxisome proliferator-activated receptor-alpha in acute pancreatitis induced by cerulein. Immunology 118, 559-570.
10. Malleo, G., Shah, K.J., and Siriwardena, A.K. (2006) The relevance of experimental models of acute pancreatitis. In Association of Surgeons in Training (Thirtieth Anniversary) Yearbook. pp. 84-86.
11. Norman, J.G., Fink, G.W., and Franz, M.G. (1995) Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch. Surg. 130, 966-970.
12. Denham, W., Yang, J., Fink, G., Denham, D., Carter, G., Ward, K., and Norman, J. (1997) Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis. Gastroenterology 113, 1741-1746.
13. Gukovskaya, A.S., Gukovsky, I., Zaninovic, V., Song, M., Sandoval, D., Gukovsky, S., and Pandol, S.J. (1997) Pancreatic acinar cells produce, release, and respond to tumor necrosis factor-alpha. Role in regulating cell death and pancreatitis. J. Clin. Invest. 100, 1853-1862.
14. Mayer, J.M. (2005) Shifting the focus from leukocyte to acinar cell: which is the more important mediator of pancreatic inflammation? Crit. Care Med. 33, 248.
15. Vaccaro, M.I., Ropolo, A., Grasso, D., Calvo, E.L., Ferreria, M., Iovanna, J.L., and Lanosa, G. (2000) Pancreatic acinar cells submitted to stress activate TNF-alpha gene expression. Biochem. Biophys. Res. Commun. 268, 485-490.
16. Ramudo, L., Manso, M.A., Sevillano, S., and De Dios, I. (2005) Kinetic study of TNF-alpha production and its regulatory mechanisms in acinar cells during acute pancreatitis induced by bile-pancreatic duct obstruction. J. Pathol. 206, 9-16.
17. Ramudo, L., Manso, M.A., Vicente, S., and De Dios, I. (2005) Pro- and anti-inflammatory response of acinar cells during acute pancreatitis. Effect of N-acetyl cysteine. Cytokine 32, 125-131.
18. Ramudo, L., Manso, M.A., and De Dios, I. (2005) Biliary pancreatitis-associated ascitic fluid activates the production of tumor necrosis factor-α in acinar cells. Crit. Care Med. 33, 143-148.
19. De Dios, I., Ramudo, L., Alonso, J.R., Recio, J.S., Garcia-Montero, A.C., and Manso, M.A. (2005) CD45 expression on rat acinar cells: involvement in pro-inflammatory cytokine production. FEBS Lett. 579, 6355-6360.
20. De Dios, I., Ramudo, L., Garcia-Montero, A., and Manso, M. (2006) Redox-sensitive modulation of CD45 expression in pancreatic acinar cells during acute pancreatitis. J. Pathol. 210, 234-239.
21. Vona-Davis, L., Yu, A., Magabo, K., Evans, T., Jackson, B., Riggs, D., and McFadden, D. (2004) Peptide YY attenuates transcription factor activity in tumor necrosis factor-alpha-induced pancreatitis. J. Am. Coll. Surg. 199, 87-95.
22. Virlos, I., Mazzon, E., Serraino, I., Di Paola, R., Genovese, T., Britti, D., Thiemerman, C., Siriwardena, A.K., and Cuzzocrea, S. (2003) Pyrrolidine dithiocarbamate reduces the severity of cerulein-induced murine acute pancreatitis. Shock 20, 544-550.
23. Virlos, I., Mazzon, E., Serraino, I., Genovese, T., Di Paola, R., Thiemerman, C., Siriwardena, A.K., and Cuzzocrea, S. (2004) Calpain I inhibitor ameliorates the indices of disease severity in a murine model of cerulein-induced acute pancreatitis. Intensive Care Med. 30, 1645-1651.
24. Balachandra, S., Genovese, T., Mazzon, E., Di Paola, R., Thiemerman, C., Siriwardena, A.K., and Cuzzocrea, S. (2005) Inhibition of tyrosine-kinase- mediated cellular signaling by tyrphostins AG 126 and AG556 modulates murine experimental acute pancreatitis. Surgery 138, 913-923.
25. Cuzzocrea, S., Pisano, B., Dugo, L., Ianaro, A., Britti, D., Patel, N.S., Di Paola, R., Genovese, T., Di Rosa, M., Caputi, A.P., and Thiemermann, C. (2004) Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute pancreatitis induced by cerulein. Intensive Care Med. 30, 951-956.
26. Grady, T., Dabrowski, A., Williams, J.A., and Logsdon, C.D. (1996) Stress-activated protein kinase activation is the earliest direct correlate to the induction of secretagogue-induced pancreatitis in rats. Biochem. Biophys. Res. Commun. 227, 1-7.
27. Minutoli, L., Altavilla, D., Marini, H., Passaniti, M., Bitto, A., Seminara, P., Venuti, F.S., Famulari, C., Macri, A., Versaci, A., and Squadrito, F. (2004) Protective effects of SP600125 a new inhibitor of c-jun N-terminal kinase (JNK) and extracellular-regulated kinase (ERK1/2) in an experimental model of cerulein-induced pancreatitis. Life Sci. 75, 2853-2866.
28. Wagner, A.C., Mazzucchelli, L., Miller, M., Camoratto, A.M., and Goke, B. (2000) CEP-1347 inhibits caerulein-induced rat pancreatic JNK activation and ameliorates caerulein pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 278, 165-172.
29. Satoh, A., Gukovskaya, A.S., Edderkaoui, M., Daghighian, M.S., Reeve, J.R., Shimosegawa, T., and Pandol, S.J. (2005) Tumor necrosis factor-α mediates pancreatitis responses in acinar cells via protein kinase C and proline-rich tyrosine kinase 2. Gastroenterology 129, 639-651.
30. Friedl, H.P., Till, G.O., Ryan, U.S., and Ward, P.A. (1989) Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J. 3, 2512-2518.
31. Genovese, T., Mazzon, E., Di Paola, R., Muià, C., Crisafulli, C., Menegazzi, M., Malleo, G., Suzuki, H., and Cuzzocrea, S. (2006) Hypericum perforatum attenuates the development of cerulein-induced acute pancreatitis in mice. Shock 25, 161-167.
32. Kimura, Y., Hirota, M., Okabe, A., Inoue, K., Kuwata, K., Ohmuraya, M., and Ogawa, M. (2003) Dynamic aspects of granulocyte activation in rat severe acute pancreatitis. Pancreas 27, 127-132.
33. Cuzzocrea, S., Rossi, A., Serraino, I., Di Paola, R., Dugo, L., Genovese, T., Britti, D., Sciarra, G., De Sarro, A., Caputi, A.P., and Sautebin, L. (2003) 5-Lipoxygenase knockout mice exhibit a resistance to acute pancreatitis induced by cerulein. Immunology 110, 120-130.
34. Cuzzocrea, S., Mazzon, E., Dugo, L., Serraino, I., Centorrino, T., Ciccolo, A., Van de Loo, F.A., Britti, D., Caputi, A.P., and Thiemermann, C. (2002) Inducible nitric oxide synthase-deficient mice exhibit resistance to the acute pancreatitis induced by cerulein. Shock 17, 416-422.
35. Cuzzocrea, S., Genovese, T., Mazzon, E., Di Paola, R., Muia, C., Britti, D., and Salvemini, D. (2004) Reduction in the development of cerulein-induced acute pancreatitis by treatment with M40401, a new selective superoxide dismutase mimetic. Shock 22, 254-261.
36. Mazzon, E., Genovese, T., Di Paola, R., Muià, C., Crisafulli, C., Malleo, G., Esposito, E., Meli, R., Sessa, E., and Cuzzocrea, S. (2006) Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein. Eur. J. Pharmacol. 549, 149-156.
37. Mota, R.A., Sanchez-Bueno, F., Saenz, L., Hernandez-Espinosa, D., Jimeno, J., Tornel, P.L., Martinez-Torrano, A., Ramirez, P., Parrilla, P., and Yelamos, J. (2005) Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury. Lab. Invest. 85, 1250-1262.
38. Rau, B., Paszkowski, A., Esber, S., Gansauge, F., Poch, B., Beger, H.G., and Moller, P. (2001) Anti-ICAM-1 antibody modulates late onset of acinar cell apoptosis and early necrosis in taurocholate-induced experimental acute pancreatitis. Pancreas 23, 80-88.
39. Folch, E., Salas, A., Panes, J., Gelpi, E., Rosello-Catafau, J., Anderson, D.C., Navarro, S., Pique, J.M., Fernandez-Cruz, L., and Closa, D. (1999) Role of P-selectin and ICAM-1 in pancreatitis-induced lung inflammation in rats: significance of oxidative stress. Ann. Surg. 230, 792-798.
40. Lundberg, A.H., Granger, N., Russell, J., Callicutt, S., Gaber, L.W., Kotb, M., Sabek, O., and Gaber, A.O. (2000) Temporal correlation of tumor necrosis factor-alpha release, upregulation of pulmonary ICAM-1 and VCAM-1, neutrophil sequestration, and lung injury in diet-induced pancreatitis. J. Gastrointest. Surg. 4, 248-257.
41. de Beaux, A.C., Ross, J.A., Maingay, J.P., Fearon, K.C., and Carter, D.C. (1996) Proinflammatory cytokine release by peripheral blood mononuclear cells from patients with acute pancreatitis. Br. J. Surg. 83, 1071-1075.
42. McKay, C.J., Gallagher, G., Brooks, B., Imrie, C.W., and Baxter, J.N. (1996) Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br. J. Surg. 83, 919-923.
43. De Dios, I., Perez, M., De la Mano, A., Sevillano, S., Orfao, A., Ramudo, L., and Manso, M.A. (2002) Contribution of circulating leukocytes to cytokine production in pancreatic duct obstruction-induced acute pancreatitis in rats. Cytokine 20, 295-303.
44. Jaffray, C., Mendez, C., Denham, W., Carter, G., and Norman, J. (2000) Specific pancreatic enzymes activate macrophages to produce tumor necrosis factor-alpha: role of nuclear factor kappa B and inhibitory kappa B proteins. J. Gastrointest. Surg. 4, 370-377.
45. Geisler, F., Algul, H., Riemann, M., and Schmid, R.M. (2005) Questioning current concepts in acute pancreatitis: endotoxin contamination of porcine pancreatic elastase is responsible for experimental pancreatitis-associated distant organ failure. J. Immunol. 174, 6431-6439.
46. Mikami, Y., Takeda, K., Shibuya, K., Qiu-Feng, H., Egawa, S., Sunamura, M., and Matsuno, S. (2002) Peritoneal inflammatory cells in acute pancreatitis: relationship of infiltration dynamics and cytokine production with severity of illness. Surgery 132, 86-92.
47. Satoh, A., Shimosegawa, T., Masamune, A., Fujita, M., Koizumi, M., and Toyota, T. (1999) Ascitic fluid of experimental severe acute pancreatitis modulates the function of peritoneal macrophages. Pancreas 19, 268-275.
48. Borish, L.C. and Steinke, J.W. (2003) Cytokines and chemokines. J. Allergy Clin. Immunol. 111, 460-475.
49. Yang, J., Denham, W., Carter, G., Tracey, K.J., and Norman, J. (1998) Macrophage pacification reduces rodent pancreatitis-induced hepatocellular injury through down-regulation of hepatic tumor necrosis factor alpha and interleukin-1beta. Hepatology 28, 1282-1288.
50. Murr, M.M., Yang, J., Fier, A., Kaylor, P., Mastorides, S., and Norman, J.G. (2002) Pancreatic elastase induces liver injury by activating cytokine production within Kupffer cells via nuclear factor-kappa B. J. Gastrointest. Surg. 6, 474-480.
51. Gloor, B., Blinman, T.A., Rigberg, D.A., Todd, K.E., Lane, J.S., Hines, O.J., and Reber, H.A. (2000) Kupffer cell blockade reduces hepatic and systemic cytokine levels and lung injury in hemorrhagic pancreatitis in rats. Pancreas 21, 414-420.
52. Folch, E., Serrano, A., Sabater, L., Gelpi, E., Rosello-Catafau, J., and Closa, D. (2001) Soluble receptors released during acute pancreatitis interfere with the detection of tumor necrosis factor-alpha. Crit. Care Med. 29, 1023-1026.
53. Granell, S., Pereda, J., Gomez-Cambronero, L., Cassinello, N., Sabater, L., Closa, D., and Sastre, J. (2004) Circulating TNF-alpha and its soluble receptors during experimental acute pancreatitis. Cytokine 25, 187-191.
54. Alsfasser, G., Antoniu, B., Thayer, S.P., Warshaw, A.L., and Fernandez-del Castillo, C. (2005) Degradation and inactivation of plasma tumor necrosis factor-alpha by pancreatic proteases in experimental acute pancreatitis. Pancreatology 5, 37-43.
55. Kaiser, A.M., Saluja, A.K., Sengupta, A., Saluja, M., and Steer, M.L. (1995) Relationship between severity, necrosis, and apoptosis in five models of experimental acute pancreatitis. Am. J. Physiol. 269, 1295-1304.
56. Bhatia, M., Wallig. M.A., Hofbauer, B., Lee, H.S., Frossard, J.L., Steer, M.L., and Saluja, A.K. (1998) Induction of apoptosis in pancreatic acinar cells reduces the severity of acute pancreatitis. Biochem. Biophys. Res. Commun. 246, 476-483.
57. Guzman, E.A. and Rudnicki, M. (2006) Intricacies of host response in acute pancreatitis. J. Am. Coll. Surg. 202, 509-519.
58. Gomez, G., Lee, H.M., He, Q., Englander, E.W., Uchida, T., and Greeley, G.H., Jr. (2001) Acute pancreatitis signals activation of apoptosis-associated and survival genes in mice. Exp. Biol. Med. 226, 692-700.
59. Yasuda, H., Kataoka, K., Ichimura, H., Mitsuyoshi, M., Iida, T., Kita, M., and Imanishi, J. (1999) Cytokine expression and induction of acinar cell apoptosis after pancreatic duct ligation in mice. J. Interferon Cytokine Res. 19, 637-644.
60. Gukovsky, I., Reyes, C.N., Vaquero, E.C., Gukovskaya, A.S., and Pandol, S.J. (2003) Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G85-95.
61. Gukovskaya, A.S. and Pandol, S.J. (2004) Cell death pathways in pancreatitis and pancreatic cancer. Pancreatology 4, 567-586.
62. Malka, D., Vasseur, S., Bodeker, H., Ortiz, E.M., Dusetti, N.J., Verrando, P., Dagorn, J.C., and Iovanna, J.L. (2000) Tumor necrosis factor alpha triggers antiapoptotic mechanisms in rat pancreatic cells through pancreatitis-associated protein I activation. Gastroenterology 119, 816-828.
63. Holler, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.L., Schneider, P., Seed, B., and Tschopp, J. (2000) Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1, 489-495.
64. Mareninova, O.A., Sung, K.F., Hong, P., Lugea, A., Pandol, S.J., Gukovsky, I., and Gukovskaya, A.S. (2006) Cell death in pancreatitis: caspases protect from necrotizing pancreatitis. J. Biol. Chem. 281, 3370-3381.
65. Berger, H.G., Rau, B., Isenmann, R., Schwarz, M., Gansauge, F., and Poch, B. (2005) Antibiotic prophylaxis in severe acute pancreatitis. Pancreatology 5, 10-19.
66. Neoptolemos, J.P., Carr-Locke, D.L., London, N.J., Bailey, I.A., James, D., and Fossard, D.P. (1988) Controlled trial of urgent endoscopic retrograde cholangiopancreatography and endoscopic sphincterotomy versus conservative treatment for acute pancreatitis due to gallstones. Lancet 2, 979-983.
67. Grewal, H.P., Mohey el Din, A., Gaber, L., Kotb, M., and Gaber, A.O. (1994) Amelioration of the physiologic and biochemical changes of acute pancreatitis using an anti-TNF-alpha polyclonal antibody. Am. J. Surg. 167, 214-218.
68. Reinhart, K., Wiegand-Lohnert, C., Grimminger, F., Kaul, M., Withington, S., Treacher, D., Eckart, J., Willatts, S., Bouza, C., Krausch, D., Stockenhuber, F., Eiselstein, J., Daum, L., and Kempeni, J. (1996) Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Crit. Care Med. 24, 733-742.
69. Tracey, K.J., Fong, Y., Hesse, D.G., Manogue, K.R., Lee, A.T., Kuo, G.C., Lowry, S.F., and Cerami, A. (1987) Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330, 662-664.
70. Oruc, N., Ozutemiz, O., Yukelsen, V., Nart, D., Celik, H.A., Yuce, G., and Batur, Y. (2004) Infliximab: a new therapeutic agent in acute pancreatitis? Pancreas 28, 1-8.
71. Norman, J.G., Fink, G.W., Messina, J., Carter, G., and Franz, M.G. (1996) Timing of tumor necrosis factor antagonism is critical in determining outcome in murine lethal acute pancreatitis. Surgery 120, 515-521.
72. Malleo, G., Mazzon, E., Genovese, T., Di Paola, R., Muià, C., Centorrino, T., Siriwardena, A.K., and Cuzzocrea, S. (2007) Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice. A comparison with TNF-α genetic deletion. Shock, in press.
73. Malleo, G., Mazzon, E., Genovese, T., Di Paola, R., Muià, C., Crisafulli, C., Siriwardena, A.K., and Cuzzocrea, S. (2007) Effects of thalidomide in a mouse model of cerulein-induced acute pancreatitis. Shock, in press.
74. Marriott, J.B., Westby, M., Cookson, S., Guckian, M., Goodbourn, S., Muller, G., Shire, M.G., Stirling, D., and Dalgleish, A.G. (1998) CC-3052: a water-soluble analog of thalidomide and potent inhibitor of activation-induced TNF-alpha production. J. Immunol. 161, 4236-4243.
75. Gerard, C., Bruyns, C., Marchant, A., Abramowicz, D., Vandenabeele, P., Delvaux, A., Fiers, W., Goldman, M., and Velu, T. (1993) Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177, 547-550.
76. Muchamuel, T., Menon, S., Pisacane, P., Howard, M.C., and Cockayne, D.A. (1997) IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. J. Immunol. 158, 2898-2903.
77. Badger, A.M., Olivera, D., Talmadge, J.E., and Hanna, N. (1989) Protective effect of SK&F 86002, a novel dual inhibitor of arachidonic acid metabolism, in murine models of endotoxin shock: inhibition of tumor necrosis factor as a possible mechanism of action. Circ. Shock. 27, 51-61.
78. Dlugosz, JW., Andrzejewska, A., Wroblewski, E., Poplawski, C., and Wereszczynska-Siemiatkowska, U. (2004) Beneficial effect of iloprost on the course of acute taurocholate pancreatitis in rats and its limitation by antecedent acute ethanol intake. Exp. Toxicol. Pathol. 55, 401-409.
79. Sato, T., Otaka, M., Odashima, M., Kato, S., Jin, M., Konishi, N., Matsuhashi, T., and Watanabe, S. (2006) Specific type IV phosphodiesterase inhibitor ameliorates cerulein-induced pancreatitis in rats. Biochem. Biophys. Res. Commun. 346, 339-344.
80. Gomez-Cambronero, L., Camps, B., de La Asuncion, J.G., Cerda, M., Pellin, A., Pallardo, F.V., Calvete, J., Sweiry, J.H., Mann, G.E., Vina, J., and Sastre, J. (2000) Pentoxifylline ameliorates cerulein-induced pancreatitis in rats: role of glutathione and nitric oxide. J. Pharmacol. Exp. Ther. 293, 670-676.
81. Marton, J., Farkas, G., Takacs, T., Nagy, Z., Szasz, Z., Varga, J., Jarmay, K., Balogh, A., and Lonovics, J. (1998) Beneficial effects of pentoxifylline treatment of experimental acute pancreatitis in rats. Res. Exp. Med. (Berl.) 197, 293-299.
82. th, Fernandez-del Castello, C., Antoniu, B.A., and Warshaw, A.L. (2002) Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology 122, 188-201.
83. rd, Borcherding, D.R., Silverstein, R., and Morrison, D.C. (1993) Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge. J. Immunol. 151, 389-396.
84. Cohen, P.S., Nakshatri, H., Tennis, J., Carabine, T., Bianchi, M., Cerami, A., and Tracey, K.J. (1996) CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proc. Natl. Acad. Sci. U. S. A. 93, 3967-3971.
85. Lorente, J.A. and Marshall, J.C. (2005) Neutralization of tumor necrosis factor in preclinical models of sepsis. Shock 24, 107-119.
86. Abraham, E., Wunderink, R., Silverman, H., Perl, T.M., Nasraway, S., Levy, H., Bone, R., Wenzel, R.P., Balk, R., Allred, R., et al. (1995) Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA 273, 934-941.
87. Dhainaut, J.F., Vincent, J.L., Richard, C., Lejeune, P., Martin, C., Fierobe, L., Stephens, S., Ney, U.M., and Sopwith, M. (1995) CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group. Crit. Care Med. 23, 1461-1469.
88. Reinhart, K., Wiegand-Lohnert, C., Grimminger, F., Kaul, M., Withington, S., Treacher, D., Eckart, J., Willatts, S., Bouza, C., Krausch, D., Stockenhuber, F., Eiselstein, J., Daum, L., and Kempeni, J. (1996) Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study. Crit. Care Med. 24, 733-742.
89. Hirano, T. (1999) Cytokine suppressive agent improves survival rate in rats with acute pancreatitis of closed duodenal loop. J. Surg. Res. 81, 224-229.
90. Denham, W., Fink, G., Yang, J., Ulrich, P., Tracey, K., and Norman, J. (1997) Small molecule inhibition of tumor necrosis factor gene processing during acute pancreatitis prevents cytokine cascade progression and attenuates pancreatitis severity. Am. Surg. 63, 1045-1049.
91. Pereda, J., Sabater, L., Cassinello, N., Gòmez-Cambronero, L., Closa, D., Folch-Puy, E., Aparisi, L., Calvete, J., Cerdà, M., Lledò, S., Viña, J., and Sastre, J. (2004) Effect of simultaneous inhibition of TNF- alpha production and xanthine oxidase in experimental acute pancreatitis: the role of mitogen activated protein kinases. Ann. Surg. 240, 108-116.
92. Hughes, C.B., Grewal, H.P., Gaber, L.W., Kotb, M., Mohey el-Din, A.B., Mann, L., and Gaber, A.O. (1996) Anti-TNFalpha therapy improves survival and ameliorates the pathophysiologic sequelae in acute pancreatitis in the rat. Am. J. Surg. 171, 274-280.
93. Hughes, C.B., Gaber, L.W., Mohey el-Din, A.B., Grewal, H.P., Kotb, M., Mann, L., and Gaber, A,O. (1996) Inhibition of TNF alpha improves survival in an experimental model of acute pancreatitis. Am. Surg. 62, 8-13.
94. Mason, J. and Siriwardena, A.K. (2005) Designing future clinical trials in acute pancreatitis. Pancreatology 5, 113-115.
95. Jin, H., Yang, R., Marsters, S.A., Bunting, S.A., Wurm, F.M., Chamow, S.M., and Ashkenazi, A. (1994) Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoadhesin: comparison with anti-TNF monoclonal antibody. J. Infect. Dis. 170, 1323-1326.
96. Mann, D.L., McMurray, J.J., Packer, M., Swedberg, K., Borer, J.S., Colucci, W.S., Djian, J., Drexler, H., Feldman, A., Kober, L., Krum, H., Liu, P., Nieminen, M., Tavazzi, L., van Veldhuisen, D.J., Waldenstrom, A., Warren, M., Westheim, A., Zannad, F., and Fleming, T. (2004) Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation 109, 1594-1602.
97. Chung, E.S., Packer, M., Lo, K.H., Fasanmade, A.A., Willerson, J.T.; Anti-TNF Therapy Against Congestive Heart Failure Investigators (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107, 3133-3140.
98. Bongartz, T., Sutton, A.J., Sweeting, M.J., Buchan, I., Matteson, E.L., and Montori, V. (2006) Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295, 2275-2285.